Table II.
Outcome | Visits IPV exposed | Visits IPV unexposed | RR (95% CI)¥ | χ2 (df) | aRR (95% CI)2 | χ2 (df) |
---|---|---|---|---|---|---|
n (%) | n (%) | |||||
Detectable plasma viral load1 | 3/88 (3.4) | 65/482 (13.5) | 0.25 (0.06, 1.08) | 3.42 (1) | 0.21 (0.05, 0.84) | 14.0 (5)* |
Late refill (>48 hours)2 | 81/517 (15.7) | 479/2,672 (18.0) | 0.87 (0.65, 1.18) | 0.76 (1) | 0.84 (0.61, 1.14) | 8.01 (5) |
< 80% by self-rating scale3 | 5/530 (1.0) | 13/2,661 (0.50) | 1.93 (0.68, 5.47) | 1.23 (1) | 1.58 (0.52, 4.74) | 8.23 (5) |
p-value<0.05
**; p-value<0.01
***; p-value<0.001
ART, antiretroviral adherence; df, degrees of freedom; IPV, intimate partner violence; PVL, plasma viral load; RR, Relative Risk; aRR, adjusted Relative Risk
RRs estimated using generalized estimating equations with log link, independence correlation structure and robust standard errors. The Wald (Chi-squared) test was used for all test statistics.
Multivariate models adjusted for age (restricted cubic spline) and education (<8 vs. 8 or more years)
≥180 viral copies per milliliter. The adjusted model and included 195 women and 570 visits when viral load testing was performed.
The adjusted model included 214 women and 3,189 visits when women were taking ART.
The adjusted model included 213 women and 3,190 visits when women were taking ART.